Design Therapeutics (DSGN) announced the appointment of Chris Storgard, M.D., as Chief Medical Officer. Most recently, Dr. Storgard served as CMO at ADARx Pharmaceuticals, where he transitioned the organization from research to development-stage operations, overseeing the advancement of multiple clinical programs, including preparations for the company’s first global Phase 3 program.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DSGN:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue